Home / Health / Delhi Seizes 31,700 Oxytocin Injections Due to Poor Storage
Delhi Seizes 31,700 Oxytocin Injections Due to Poor Storage
11 Jul
Summary
- Over 31,700 oxytocin injections were seized for improper storage.
- The critical drug was stored at room temperature, losing efficacy.
- Further investigations are underway to track distributed batches.
The Delhi Drugs Control Department confiscated a substantial quantity of over 31,700 oxytocin injections on Thursday. The seizure occurred at a pharmaceutical firm located in the Patparganj Industrial Area, following intelligence that indicated improper cold-chain storage practices for this vital drug.
Inspecting officials discovered that the oxytocin injections, identified as Oxywin (oxytocin injection IP 5 IU/ml), were being kept at ambient room temperature. This practice violates the mandatory storage requirement of 2°C to 8°C, a condition crucial for maintaining the drug's efficacy and ensuring public health safety.
Reports suggest the seized stock was procured in May 2026 and had been stored under these substandard conditions since its arrival. Authorities are now gathering information on previously supplied quantities to facilitate stop-sale orders and potential recalls. This action is part of a broader crackdown on oxytocin supplies amid ongoing quality concerns.
